Current Opinion in Oncology

Article	Citations
Progress in diagnosis and treatment of checkpoint inhibitor pneumonitis	42
Editorial introductions	33
Treatments and challenges in advanced prostate cancer	30
Optimal management of oligometastatic prostate cancer: current state and future directions	29
Circulating tumor DNA in human papilloma virus negative head and neck squamous cell carcinoma	29
State of the art and upcoming trends in HER2-directed therapies in gastrointestinal malignancies	22
Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy	21
Collecting information from all sarcoma reference cancer centres worldwide: achievement and next steps	20
The role of signaling lymphocyte activation molecule family receptors in hematologic malignancies	17
Neurorehabilitation in brain tumours: evidences and suggestions for spreading of knowledge and research implementation	16
Role of PSMA PET/CT in imaging and management of prostate cancer	16
Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint?	14
Epigenetic dynamics of aging and cancer development: current concepts from studies mapping aging and cancer epigenomes	14
Cancer survivors living with chronic pain: patient and healthcare professional perspectives and current recommendations	14
Editorial introductions	14
Editorial introductions	13
How to prevent human papillomavirus-related oropharyngeal cancer?	13
Can we yet use tertiary lymphoid structures as predictive biomarkers for immunotherapy response in melanoma?	13
Local treatment in patients with hereditary breast cancer: decision-making process in low-, moderate-, high-penetrance pathogenic germline mutation carriers	13
Neoadjuvant and adjuvant approaches in gastroesophageal cancers	13
Safety of assisted reproductive techniques in gynecological cancer patients	13
Biomarkers and immunotherapy: where are we?	13
Impact of sentinel node use in lymphedema formation among gynecologic cancer patients	13
WHO 2021 and beyond: new types, molecular markers and tools for brain tumor classification	12
Enhancing proactive life-sustaining treatment preference documentation in advanced cancer care: barriers and recommendations	12

Indications and technique of minimally invasive surgery in early-stage cervical cancer	12
New hopes in relapsed refractory primary central nervous system lymphoma	12
Circulating tumor DNA in breast cancer: a biomarker for patient selection	12
Beyond ‘the good, the bad and the ugly’: let us put rectal cancer patients at the centre of the decision making	12
State-of-the-art and trends in fibroblast growth factor receptor-directed therapies in gastro-intestinal malignancies	12
Open questions on vorasidenib	12
Pregnancy-related hormonal changes and thyroid growth: do they have an impact on the higher incidence of differentiated thyroid cancer in women?	11
Editorial introductions	10
A meta-analysis of the efficacy and toxicity of tyrosine kinase inhibitors in treating patients with different types of thyroid cancer: how to choose drugs appropriately?	10
Controversies in central nervous system prophylaxis of high-risk diffuse large B-cell lymphoma	10
Recent advances in precision medicine for acute myeloid leukemia	10
The evolving landscape of bispecific antibodies in the treatment of lung cancer	10
Recent highlights and breakthroughs in immunotherapy for head and neck cancers	10
Pathology and new insights in central nervous system lymphomas	9
State-of-the-art and upcoming trends in RAS-directed therapies in gastrointestinal malignancies	9
Interventions aiming to improve advance care planning uptake in oncology: a scoping review of recent randomized controlled trials	9
Liquid biopsy in brain tumors: moving on, slowly	9
Current evidence of integrative oncology modalities for managing adverse effects and survivorship issues among adolescents and young adult (AYA) cancer patients and survivors	9
Lung cancer screening in never smokers	8
Artificial intelligence in lung cancer: from diagnosis to therapy	8
Machine learning applications and challenges in graft-versus-host disease: a scoping review	8
Editorial introductions	8
Hybrid magnetic resonance and PET imaging for prostate cancer recurrence	8
A new comprehensive and stratified concept for supportive care in cancer patients	8
Multiple endocrine neoplasia type 2: towards a risk-based approach integrating molecular and biomarker results	8
Antibody–drug conjugates in rare genitourinary tumors: review and perspectives	8
Noninvasive skin imaging of melanocytic and nonmelanocytic tumours: recent findings	8
The 5T's of health disparities in multiple myeloma in Latin America	8
State of the art and upcoming trends in claudin-directed therapies in gastrointestinal malignancies	7
Breast surgery after neoadjuvant therapy	7
Controversies on chemotherapy for early HR+/HER2− breast cancer: the role of anthracyclines and dose intensification	7
Less is more in endometrial cancer (SLN, conservative treatment, radical hysterectomy, molecular classification)	7
Current role and indications of minimally invasive surgery in gynecologic oncology	7
Editorial introductions	7
Potential application of artificial intelligence in cancer therapy	7
Editorial introductions	7
Evolving paradigms in the management of basal cell carcinoma	7
Editorial introductions	7
Biochemically recurrent prostate cancer in the era of EMBARK and PSMA PET imaging: everything has changed, except the patients	7
New therapies for brain metastases: an update	7
Advantages of robotic surgery in obese patients with endometrial cancer	7
Deciphering diffuse glioma immune microenvironment as a key to improving immunotherapy results	7
Melanoma in adolescents and young adults: special considerations	7
How to become a Multinational Association of Supportive Care in Cancer-designated center of excellence in supportive care in cancer	7
Application of single-port techniques in endometrial cancer	7
Immune checkpoint inhibitors in driver mutation-positive nonsmall cell lung cancer	6
Adjuvant and neoadjuvant approaches in pancreatic cancer	6
Preclinical glioma models in neuro-oncology: enhancing translational research	6
Pathologic diagnosis of lung cancer – recent developments	6
Treatment of radiation-associated angiosarcoma	6

How to treat localized Hodgkin lymphoma?	6
Therapeutic cancer vaccination against telomerase: clinical developments in melanoma	6
When do I ask for a DNA methylation array for primary brain tumor diagnosis?	6
Global priorities for advancing cancer survivorship	6
Insulin resistance and metabolic dysfunction in thyroid nodules and differentiated thyroid cancer	6
Sarcoma incidence worldwide: regional differences in histology and molecular subtypes	6
Precision, personalization, and quality of life for patients with lymphoma	6
Modeling the management of patients with human epidermal growth factor receptor 2-positive breast cancer with liquid biopsy: the future of precision medicine	6
Cellular therapies in sarcoma and other solid tumors	6
Editorial introductions	6
Targeting cancer stem cell pathways for lung cancer therapy	6
HER2-positive breast cancer: cotargeting to overcome treatment resistance	6
Immunotherapies in non-metastatic gastrointestinal cancers	6
Advances in the pathogenesis of FLT3-mutated acute myeloid leukemia and targeted treatments	6
Achievements of international rare cancers networks and consortia in the neuro-oncology field	6
How to monitor the side effects of treatments in cancer patients	6
Is there role of adjuvant radiotherapy after complete resection of locally advanced nonsmall cell lung cancer?	5
Clinical management of brain tumors in pregnancy	5
Unclear territory: navigating metastatic nonclear cell renal cell carcinoma	5
Predictors of response to CD19 chimeric antigen receptor T-cell therapy in large B-cell lymphoma: a consolidated review	5
Editorial	5
Doxorubicin combined with Trabectedin in systemic first-line M+/recurrent leiomyosarcoma patients	5
Thymic malignancies: role of immunotherapy and novel approaches	5
Endoscopic inguinal lymphadenectomy for vulvar cancer, is it feasible?	5
Patient-proxy agreement on health-related quality of life assessment in cancer patients	5
Update on bi-specific monoclonal antibodies for blood cancers	5
Neoadjuvant immune checkpoint blockade enhances local and systemic tumor immunity in head and neck cancer	5
High-risk smoldering myeloma – a case for early intervention?	5
Targeting exon 20 insertion mutations in lung cancer	5
Are epigenetic-targeting approaches ready for prime time in neuroendocrine neoplasms?	5
Richter transformation: biological insights, diagnostic challenges and emerging therapies	5
Polyamine metabolism in prostate cancer	5
Lifestyle medicine for cancer survivorship	5
Editorial introductions	5
New trends in supportive care of head and neck cancers	4
Update of antibody–drug conjugates for hematological malignancies	4
Current opinion on laparoscopic surgery in gynecologic oncology: challenges and advances in elderly patients	4
Treatment of lung cancer in pregnant women	4
How to treat advanced Hodgkin lymphoma?	4
Editorial introductions	4
State of the art and future directions in the treatment of metastatic adenoid cystic carcinoma	4
Molecular genotyping in medullary thyroid cancer	4
Recent advances in immunotherapy for small cell lung cancer	4
RANO 2.0 criteria: concepts applicable to the neuroradiologist's clinical practice	4
Supportive care in the world: an international opinion on MASCC's perspectives	4
Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours	4
Early Detection of Cancers in the Era of Precision Oncology	4
Targeting poly(ADP-ribose) polymerase in metastatic prostate cancer: current landscape and future directions	4
Perioperative immunotherapy in nonsmall cell lung cancer	4
Precision medicine in extended adjuvant endocrine therapy for breast cancer	4
Future of sentinel node biopsy in ovarian cancer	4
Epithelioid sarcoma: from SMARCB1 loss to therapeutic vulnerabilities	4
Ovarian stimulation and oocyte cryopreservation in females with cancer	4
Advances in the treatment of light chain amyloidosis	3
Postneoadjuvant treatment for triple-negative breast cancer	3
Artificial intelligence for systemic therapy selection and prediction of outcomes in advanced gynecological cancers	3
Advances in testing for human papillomavirus-mediated head and neck cancer	3
Unveiling the role of cellular dormancy in cancer progression and recurrence	3
Emerging therapies in Ewing sarcoma	3
Clinical utility of genomic signatures for the management of early and metastatic triple-negative breast cancer	3
Advance care planning in oncology: a scoping review and some recommendations	3
Circulating tumour DNA dynamics for assessment of molecular residual disease and for intercepting resistance in breast cancer	3
Editorial introductions	3
Epidemiology trends and progress in breast cancer survival: earlier diagnosis, new therapeutics	3
Cancer-associated thrombosis: what is new?	3
Editorial: Advanced care planning	3
Recent advances in allogeneic transplantation for acute myeloid leukemia	3
Targeting androgen receptors in patients with metastatic breast cancer	3
Challenges in the management of relapsed germ cell tumors	3
Implementation of the 2024 ASCO guidelines for the prevention and management of osteoradionecrosis in patients with head & neck cancer treated with radiation therapy	3
Perioperative immunotherapy for nonsmall cell lung cancer	3
Editorial introductions	3
Targeting Harvey rat sarcoma viral oncogene homolog in head and neck cancer: how to move forward?	3
The role of next-generation sequencing in acute myeloid leukemia	3
Novel therapeutic agents for myelofibrosis after failure or suboptimal response to JAK2 inhbitors	3
Editorial Introductions	3
Monitoring serum estradiol in premenopausal women with hormone receptor-positive breast cancer on adjuvant LHRH agonists	3
New targeted treatments for advanced sarcomas	3
Robot-assisted laparoscopic staging compared to conventional laparoscopic staging and laparotomic staging in clinical early stage ovarian carcinoma	3
New treatments for desmoid tumors	3

New strategies for the treatment of breast cancer with leptomeningeal metastasis	3
Minimally invasive surgery in advanced and recurrent ovarian cancer: current evidence and future directions	3
Reframing distress in oncology: the potential of psychedelic-assisted therapy	3
Highlights of recent research focused on the treatment of advanced prostate cancer	3
Single agent vs combination immunotherapy in advanced melanoma: a review of the evidence	3
New treatment strategies for primary central nervous system lymphoma	3
Evolving systemic management of urothelial cancers	3
Novel immunotherapeutic approaches in lung cancer: driving beyond programmed death-1/programmed death ligand-1 and cytotoxic T-lymphocyte-associated Protein-4	3
Clinician's guide to targeted estrogen receptor degradation using PROTAC in patients with estrogen receptor-positive metastatic breast cancer	3
Action against thoracic cancers: recent achievements and perspectives	3
Immunotherapy for inflammatory breast cancer: current evidences and future perspectives	3
Circulating tumor DNA for human papilloma virus-positive disease: ready for prime time?	2
Editorial: Advances in cancer detection and diagnosis: from liquid biopsies and molecular biomarkers to opportunistic intratumoral bacteria	2
Monitoring advanced gastrointestinal stromal tumor with circulating tumor DNA	2
Two is company, is three a crowd? Triplet therapy, novel molecular targets, and updates on the management of advanced renal cell carcinoma	2
Liquid biopsy in breast cancer: promises and challenges	2
The potential roles of antibody-drug conjugates in head and neck squamous cell carcinoma	2
Primary central nervous system lymphoma (PCNSL) in older patients	2
Surrogate endpoints for HTA decisions of breast cancer drugs: utility and pitfalls	2
Immune checkpoint inhibitors in elderly patients with lung cancer: evidence from phase 3 trials	2
Immunotherapy in the neoadjuvant treatment of hormone receptor-positive/HER2-negative early breast cancer: novel approaches and future perspectives	2
Recent developments and outstanding challenges in germ cell tumors	2
Sarculator: how to improve further prognostication of all sarcomas	2
Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis	2
Liquid biopsy in head neck cancer: ready for clinical routine diagnostics?	2
T-cell redirecting bispecific and trispecific antibodies in multiple myeloma beyond BCMA	2
Circulating tumor DNA in early-stage triple-negative breast cancer: clinical landscape and key open challenges	2
Chimeric antigen receptor T-cell therapy for multiple myeloma	2
Beyond the usual – Atypical imaging presentation in lung cancer and implications for TNM-staging	2
Editorial introductions	2
Chemotherapy-induced nausea and vomiting: can we do better?	2
Implementation of sentinel node biopsy in high-risk endometrial cancer	2
Getting personal in metastatic melanoma: neoantigen-based vaccines as a new therapeutic strategy	2
Active surveillance and emerging medical treatment options for desmoid: when and for whom?	2
The role of menin inhibitors in acute myeloid leukemia	2
Treatment approaches for older Hodgkin lymphoma patients	2
Neoadjuvant chemotherapy for resectable colon cancer in the era of precision oncology: a step forward or a step back?	2
Circulating tumor DNA in B cell lymphomas	2
A meta-analysis on the risk of infection associated with intravenous iron therapy in cancer-associated anaemia: a double-edged sword?	2
Immuno-oncology in the daily practice	2
The impact of new and emerging agents on outcomes for febrile neutropenia: addressing clinical gaps	2
Novel PET tracers in breast cancer for treatment optimization: clinical utility and future perspectives	2
New targeted therapies in liposarcoma: state of art and future perspectives	2
Prognostic factors in primary central nervous system lymphoma	2
Medical treatment of angiosarcomas	2
Reirradiation in recurrent glioblastoma	2
Systemic therapy of nonsmall cell lung cancer: breakthroughs during the last five decades	2
Modern treatment approaches to adult acute T-lymphoblastic and myeloid/T-lymphoblastic leukemia: from current standards to precision medicine	2
Editorial: Less is more in gynaecological oncology: paving the way for the future	2
First line treatments in primary central nervous system lymphomas in young patients	2